Invention Grant
- Patent Title: Interfering RNA molecules
-
Application No.: US16403373Application Date: 2019-05-03
-
Publication No.: US10774332B2Publication Date: 2020-09-15
- Inventor: Klaus Giese , Jörg Kaufmann , Anke Klippel-Giese
- Applicant: Silence Therapeutics GMBH
- Applicant Address: DE Berlin
- Assignee: Silence Therapeutics GMBH
- Current Assignee: Silence Therapeutics GMBH
- Current Assignee Address: DE Berlin
- Agency: Morrison & Foerster LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@498c0426 com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@74f3a2d7
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; C12N15/11 ; A61K31/713 ; C12N5/10 ; C12Q1/68 ; A61K38/00

Abstract:
The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second grand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended.
Public/Granted literature
- US20190390201A1 INTERFERING RNA MOLECULES Public/Granted day:2019-12-26
Information query